Fig. 1From: Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment18F-FDG PET-CT revealed progressive disease at three months after start of nivolumab, with new lung and lymph node metastases. Pleural effusion was presentBack to article page